Literature DB >> 27431218

De Novo Characterization of Genes That Contribute to High-Level Ciprofloxacin Resistance in Escherichia coli.

Thu Tran1, Qinghong Ran1, Lev Ostrer1, Arkady Khodursky2.   

Abstract

Sensitization of resistant bacteria to existing antibiotics depends on the identification of candidate targets whose activities contribute to resistance. Using a transposon insertion library in an Escherichia coli mutant that was 2,000 times less susceptible to ciprofloxacin than its parent and the relative fitness scores, we identified 19 genes that contributed to the acquired ciprofloxacin resistance and mapped the shortest genetic path that increased the antibiotic susceptibility of the resistant bacteria back to a near wild-type level.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27431218      PMCID: PMC5038283          DOI: 10.1128/AAC.00889-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Survival of recombination-deficient mutants of Escherichia coli during incubation with nalidixic acid.

Authors:  L S McDaniel; L H Rogers; W E Hill
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Authors:  Aylin Colpan; Brian Johnston; Stephen Porter; Connie Clabots; Ruth Anway; Lao Thao; Michael A Kuskowski; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Clin Infect Dis       Date:  2013-08-06       Impact factor: 9.079

Review 3.  Mechanisms of drug resistance: quinolone resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Ann N Y Acad Sci       Date:  2015-07-17       Impact factor: 5.691

4.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

5.  Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.

Authors:  Lauren Becnel Boyd; Merry J Maynard; Sonia K Morgan-Linnell; Lori Banks Horton; Richard Sucgang; Richard J Hamill; Javier Rojo Jimenez; James Versalovic; David Steffen; Lynn Zechiedrich
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

6.  The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.

Authors:  A B Khodursky; N R Cozzarelli
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

7.  Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection.

Authors:  Tomoya Baba; Takeshi Ara; Miki Hasegawa; Yuki Takai; Yoshiko Okumura; Miki Baba; Kirill A Datsenko; Masaru Tomita; Barry L Wanner; Hirotada Mori
Journal:  Mol Syst Biol       Date:  2006-02-21       Impact factor: 11.429

Review 8.  Quinolones: action and resistance updated.

Authors:  Karl Drlica; Hiroshi Hiasa; Robert Kerns; Muhammad Malik; Arkady Mustaev; Xilin Zhao
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

9.  Genetic architecture of intrinsic antibiotic susceptibility.

Authors:  Hany S Girgis; Alison K Hottes; Saeed Tavazoie
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

10.  The neglected intrinsic resistome of bacterial pathogens.

Authors:  Alicia Fajardo; Nadia Martínez-Martín; María Mercadillo; Juan C Galán; Bart Ghysels; Sandra Matthijs; Pierre Cornelis; Lutz Wiehlmann; Burkhard Tümmler; Fernando Baquero; José L Martínez
Journal:  PLoS One       Date:  2008-02-20       Impact factor: 3.240

View more
  2 in total

1.  The Use of Transposon Insertion Sequencing to Interrogate the Core Functional Genome of the Legume Symbiont Rhizobium leguminosarum.

Authors:  Benjamin J Perry; Mir S Akter; Christopher K Yost
Journal:  Front Microbiol       Date:  2016-11-22       Impact factor: 5.640

2.  DNA Damage Repair and Drug Efflux as Potential Targets for Reversing Low or Intermediate Ciprofloxacin Resistance in E. coli K-12.

Authors:  Rasmus N Klitgaard; Bimal Jana; Luca Guardabassi; Karen L Nielsen; Anders Løbner-Olesen
Journal:  Front Microbiol       Date:  2018-07-02       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.